NATCO Pharma Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| NATCOPHARM.NS | IPCALAB.BO | GRANULES.BO | AKUMS.BO | TAK | 1795.TW | |
|---|---|---|---|---|---|---|
| Market cap | 144.34B | 486.30B | 194.90B | 106.04B | 64.15B | 46.89B |
| P/E (TTM) | 12.4 | 37.1 | 35.7 | 36.4 | — | 12.4 |
| Forward P/E | 16.6 | 27.2 | 26.8 | 20.3 | 37.9 | 7.4 |
| Price/book | 1.5 | 6.0 | 4.9 | 3.2 | 1.3 | 2.0 |
| Dividend yield | 0.74% | 0.33% | 0.26% | 0.14% | 3.07% | 1.47% |
| 1-year change | −4.89% | +42.82% | +0.63% | +51.93% | +42.01% | −39.08% |
| Today | −2.05% | +5.60% | −0.43% | −2.40% | +2.40% | +0.57% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 20 min.
Latest news
All NATCOPHARM.NS news ›Natco Pharma launches generic cancer drug Carboplatin in US
Drug maker Natco Pharma on Monday announced the launch of Carboplatin Injection in the US market through its subsidiary Natco Pharma USA LLC. The product, a generic version of Paraplatin, has been launched in manufacturing collaboration…
Natco Pharma Ltd. Rights Issue: Price, Record Date, Entitlement Ratio And Key Details
Learn the steps & benefits of opening a 3-in-1 account Made by experts, it covers everything about stock market Get to know ways to check IPO allotment status Link ICICI Bank Account to avail 3-in-1 account benefits Earn interest on unused…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
thehindubusinessline.com3
-
business-standard.com1
-
digitalhealthnews.com1
-
icicidirect.com1
-
kalkine.co.in1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.